Successful treatment of recalcitrant genital ulcers of Behçet's disease with adalimumab after failure of infliximab and etanercept

Clinical and Experimental Rheumatology

Volumn 27, Issue 2 SUPPL.53, 2009, Pages

  Olivieri, Ignazio ^a   D'Angelo, S ^b   Padula, A ^b   Leccese, P ^b   Mennillo, G A ^b  

^a SAN CARLO HOSPITAL   (Italy)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

ADALIMUMAB; AZATHIOPRINE; COLCHICINE; CORTICOSTEROID; CYCLOSPORIN; ETANERCEPT; INFLIXIMAB; THALIDOMIDE;

ADULT; ANAMNESIS; BEHCET DISEASE; CASE REPORT; CLINICAL FEATURE; DRUG DOSE INCREASE; DRUG SUBSTITUTION; DRUG WITHDRAWAL; GENITAL ULCER; HUMAN; LABORATORY TEST; LETTER; MALE; PHYSICAL EXAMINATION; PRIORITY JOURNAL; TREATMENT FAILURE; TREATMENT RESPONSE;

ANTIBODIES, MONOCLONAL; BEHCET SYNDROME; HUMANS; MALE; MIDDLE AGED; ORAL ULCER; PENILE DISEASES; TREATMENT FAILURE; TUMOR NECROSIS FACTOR-ALPHA;

EID: 70350163025     PISSN: 0392856X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Letter

References (12)

1. HATEMI G, SILMAN A, BANG D et al.: EULAR recommendations for the management of Behçet's disease: report of a task force of the European Standing Committee for International Clinical Studies Including Therapeutics (ESCISIT). Ann Rheum Dis 2008 Jan 31; [Epub ahead of print].
2. SFIKAKIS PP, MARKOMICHELAKIS N, ALPSOY E et al.: Anti-TNF therapy in the management of Behçet's disease-review and basis for recommendations. Rheumatology (Oxford) 2007; 46: 736-741
3. SFIKAKIS PP, KAKLAMANIS PH, ELEZOGLOU A, KATSILAMBROS N, THEODOSSIADIS PG, PAPAEFTHIMIOU et al.: Infliximab for recurrent, sight-threatening ocular inflammation in Adamantiades-Behçet disease. Ann Intern Med 2004; 140: 404-406
4. MUSHTAQ B. SAEED T, SITUNAYAKE RD, MURRAY PI: Adalimumab for sight-threatening uveitis in Behçet's disease. Eye 2007; 21: 824-825 (Pubitemid 46909189)
5. PIPITONE N, OLIVIERI I, PADULA A et al.: Infliximab for the treatment of Neuro-Behçet's disease: a case series and review of the literature. Arthritis Rheum 2008; 59: 285-290 (Pubitemid 351272967)
6. VAN LAAR JA, MISSOTTEN T, VAN DAELE PL, JAMNITSKI A, BAARSMA GS, VAN HAGEN PM: Adalimumab: a new modality for Behçet's disease? Ann Rheum Dis 2007;66:565-566
7. BELZUNEGUI J, LÓPEZ L, PANIAGUA I, INTXAUSTI JJ, MAÍZ O: Efficacy of infliximab and adalimumab in the treatment of a patient with severe neuro-Behçet's disease. Clin Exp Rheumatol 2008; 26 (Suppl. 50): S133-4.
8. ROBERTSON LP, HICKLING P: Treatment of recalcitrant urogenital ulceration of Behçet's syndrome with infliximab. Rheumatology (Oxford) 2001; 40: 473-474
9. ESTRACH C, MPOFU S, MOOTS RJ: Behçet's syndrome: response to infliximab after failure of etanercept. Rheumatology 2002; 41: 1213-1214 (Pubitemid 35203564)
10. HAUGEBERG G, VELKEN M, JOHNSÉN V Successful treatment of genital ulcers with infliximab in Behçet's disease. Ann Rheum Dis 2004; 63: 744-745
11. MELIKOGLU M, FRESKO I, MAT C et al.: Short-term trial of etanercept in Behçet's disease: a double blind, placebo controlled study. J Rheumatol 2005; 32: 98-105. (Pubitemid 40092599)
12. ALMOZNINO G, BEN-CHETRIT E: Infliximab for the treatment of resistant oral ulcers in Behçet's disease: a case report and review of the literature. Clin Exp Rheumatol 2007; 25 (Suppl. 45): S99-102.